Monsanto Roundup Lawsuit

Friday, February 19, 2010

GlaxoSmithKline/XenoPort get negative response from FDA


Image: i.dailymail.co.uk


UK drugs giant GlaxoSmithKline and partner XenoPort have received a negative response from the US Food and Drug Administration regarding their marketing application for their restless legs syndrome (RLS) drug.

FULL STORY

Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING
Post a Comment